Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers
byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu
Updated on: January 03,2024
8

Regorafenib shown to augment antitumor effect of anti-PD-1 immunotherapy in advanced gastric cancers
byKumamoto UniversityCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-1890Fibrotic cancers such as gastric cancers are highly resistant to conventional therapies like immu
Updated on:January 03,2024
8
